Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyMarina Elena Cazzaniga, Massimiliano Mazza, G. Pinotti et al.|The Breast|2019Cited by 58
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe studyGerardo Rosati, Domenico Bilancia, Antonio Avallone et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 23
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second waveAlice Indini, Livio Blasi, Marina Schena et al.|European Journal of Cancer|2021Cited by 22
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyMarina Elena Cazzaniga, I. Vallini, Emilia Montagna et al.|Breast Cancer Research and Treatment|2021Cited by 17
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II TrialsGerardo Rosati, Roberto Bordonaro, Stefano Cordio et al.|Cancers|2019Cited by 6